Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← All Wire coverage

Situation

Definium says its LSD drug notched another Phase 3 win in anxiety disorder

3 reports · 3 domains · 14 September 2026 → 14 September 2026

Reports

3

Domains carrying it

3

First reported

14 September 2026

Latest report

14 September 2026

◆ Sectors

Biotech

◆ Where

United States

◆ Timeline

  1. 14 September 2026Definium says its LSD drug notched another Phase 3 win in anxiety disorderendpoints.news
  2. 14 September 2026Definium's LSD-based anxiety, depression drug scores another trial winreuters.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

◆ Share

ShareXLinkedInEmail

◆ Wire has not analysed this situation yet

Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.

◆ Evidence

3 reports · 3 domains

Definium says its LSD drug notched another Phase 3 wi… | Fusion42